Pneumococcal Conjugate Vaccines and Otitis Media: An Appraisal of the Clinical Trials
Streptococcus pneumoniae is the predominant otitis media pathogen and its prevention through effective vaccination could diminish childhood illness and antibiotic use. This paper reviews 5 pneumococcal conjugate vaccine (PCV) trials that used otitis media as an endpoint: Northern California Kaiser P...
Main Authors: | Mark A. Fletcher, Bernard Fritzell |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | International Journal of Otolaryngology |
Online Access: | http://dx.doi.org/10.1155/2012/312935 |
Similar Items
-
Erratum to “Pneumococcal Conjugate Vaccines and Otitis Media: An Appraisal of the Clinical Trials”
by: Mark A. Fletcher, et al.
Published: (2012-01-01) -
Pneumococcal Conjugate Vaccines and Otitis Media
by: Sylvia Taylor, et al.
Published: (2012-01-01) -
Otitis Media in Fully Vaccinated Preschool Children in the Pneumococcal Conjugate Vaccine Era
by: Saurabh Talathi MD, MPH, et al.
Published: (2017-12-01) -
Respiratory Infection and Otitis Media Visits in Relation to Pneumococcal Conjugate Vaccine Use in Saskatchewan
by: Ngoc-Hang Khuc, et al.
Published: (2013-01-01) -
The effect of immunization with pneumococcal conjugated vaccines on Streptococcus pneumoniae resistance patterns in acute otitis media
by: Tal Marom, et al.
Published: (2017-10-01)